NCT00139789View on ClinicalTrials.gov

A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Multiple Sclerosis
Interventions
DRUG

Kemstro

Trial Locations (1)

Unknown

Schwarz, Milwaukee

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00139789 - A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis | Biotech Hunter | Biotech Hunter